Publications:

---

Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors.

Frontiers In Oncology

Crabtree, Judy S JS

Publication Date: 2022

Variant appearance in text: BRAF: T599K

PubMed Link: 35747820

Variant Present in the following documents:

• Main text
• fonc-12-901435.pdf

View BVdb publication page

---

Genomic Landscape of Head and Neck Squamous Cell Carcinoma Across Different Anatomic Sites in Chinese Population.

Frontiers In Genetics

Ju, Yunhe Y; Wu, Xingrao X; Wang, Huizhen H; Li, Bin B; Long, Qing Q; Zhang, Dadong D; Chen, Hao H; Xiao, Nianqing N; Li, Fugen F; Zhang, Shiwen S; Yang, Shenggang S

Publication Date: 2021

Variant appearance in text: BRAF: T599K

PubMed Link: 34194478

Variant Present in the following documents:

• Data_Sheet_1.xlsx, sheet 6

View BVdb publication page

---

Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients.

Nature Communications

Zhang, Yongliang Y; Yao, Yu Y; Xu, Yaping Y; Li, Lifeng L; Gong, Yan Y; Zhang, Kai K; Zhang, Meng M; Guan, Yanfang Y; Chang, Lianpeng L; Xia, Xuefeng X; Li, Lin L; Jia, Shuqin S; Zeng, Qiang Q

Publication Date: 2021-01-04

Variant appearance in text: BRAF: 1796C>A; T599K

PubMed Link: 33397889

Variant Present in the following documents:

• 41467_2020_20162_MOESM6_ESM.xlsx, sheet 1

View BVdb publication page

---

Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibition.

Plos One

Allen, Amy A; Qin, Alice Can Ran ACR; Raj, Nitya N; Wang, Jiawan J; Uddin, Sharmeen S; Yao, Zhan Z; Tang, Laura L; Meyers, Paul A PA; Taylor, Barry S BS; Berger, Michael F MF; Yaeger, Rona R; Reidy-Lagunes, Diane D; Pratilas, Christine A CA

Publication Date: 2019

Variant appearance in text: BRAF: T599K

PubMed Link: 31158244

Variant Present in the following documents:

• Main text
• pone.0217399.pdf

View BVdb publication page

---

Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability.

Jco Precision Oncology

Raj, Nitya N; Shah, Ronak R; Stadler, Zsofia Z; Mukherjee, Semanti S; Chou, Joanne J; Untch, Brian B; Li, Janet J; Kelly, Virginia V; Saltz, Leonard B LB; Mandelker, Diana D; Ladanyi, Marc M; Berger, Michael F MF; Klimstra, David S DS; Reidy-Lagunes, Diane D; Osoba, Muyinat M

Publication Date: 2018

Variant appearance in text: BRAF: T599K

PubMed Link: 30687805

Variant Present in the following documents:

• Main text

View BVdb publication page

---

Competitive evolution of NSCLC tumor clones and the drug resistance mechanism of first-generation EGFR-TKIs in Chinese NSCLC patients.

Heliyon

Deng, Qinfang Q; Xie, Boxiong B; Wu, Leilei L; Ji, Xianxiu X; Li, Chao C; Feng, Li L; Fang, Qiyu Q; Bao, Yuchen Y; Li, Jialu J; Jin, Shengnan S; Ding, Chunming C; Li, Yixue Y; Zhou, Songwen S

Publication Date: 2018-12

Variant appearance in text: BRAF: T599K

PubMed Link: 30603682

Variant Present in the following documents:

• mmc2.xlsx, sheet 1

View BVdb publication page

---